Kenneth Hoberman, Chief Operating Officer at STEMLINE THERAPEUTICS INC (STML), sold 21,114 shares at $12.05 ($254K) on 2019-02-25, disclosed to the SEC on 2019-02-27.
Seasonal sale ($254k) by Chief Operating Officer — this insider has traded STML in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.05 | 10,557 | $127K | 50.0% |
| 2 | $12.05 | 10,557 | $127K | 50.0% |
| Total | $12.05 avg | 21,114 | $254K | 100% |
| Filing → |
| STML | SELL | 2020-02-28 | $148K | — | Filing → |
| STML | SELL | 2020-01-24 | $311K | — | Filing → |
| STML | SELL | 2020-01-10 | $274K | — | Filing → |